Showing results (401-410 of 437) with videos related to
Sort By:
Pageof 44
Nature|May 25, 2012
Melanoma genome sequencing reveals frequent PREX2 mutationsMichael F Berger, Eran Hodis, Timothy P Heffernan, et al.JCI Insight|November 25, 2016
Institutional implementation of clinical tumor profiling on an unselected cancer populationLynette M Sholl, Khanh Do, Priyanka Shivdasani, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2024
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal CancerHarshabad Singh, Pranshu Sahgal, Kevin Kapner, et al.Cell|January 30, 2016
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse GliomaMichele Ceccarelli, Floris P Barthel, Tathiane M Malta, et al.Cancer Cell|May 12, 2016
Comprehensive Pan-Genomic Characterization of Adrenocortical CarcinomaSiyuan Zheng, Andrew D Cherniack, Ninad Dewal, et al.JAMA Oncology|November 4, 2017
Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal AdenocarcinomaZhi Rong Qian, Douglas A Rubinson, Jonathan A Nowak, et al.Cell|October 10, 2017
Comprehensive Molecular Characterization of Muscle-Invasive Bladder CancerA Gordon Robertson, Jaegil Kim, Hikmat Al-Ahmadie, et al.Nature|February 7, 2020
Genomic basis for RNA alterations in cancer, Claudia Calabrese, Natalie R Davidson, et al.Nature Genetics|July 6, 2010
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyJordi Barretina, Barry S Taylor, Shantanu Banerji, et al.Nature Genetics|May 22, 2012
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerChristopher E Barbieri, Sylvan C Baca, Michael S Lawrence, et al.Pageof 44